medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2023, Number 2

<< Back Next >>

Rev Nefrol Dial Traspl 2023; 43 (2)

Crescentic IgA nephropathy following SARS-CoV-2 vaccination. Report of a case

Toprak Z, Ersoy YE, Zerenler GF, Demirbas MB, Kayabası H, Sit D

Language: English
References: 17
Page: 106-111
PDF size: 383.56 Kb.


ABSTRACT

Introduction: Studies have shown that the frequency of acute kidney injury (AKI) increases in patients with COVID-19. Acute tubular necrosis has been reported to be the most common damage in these patients, probably due to impaired renal perfusion. On the other hand, different complex pathophysiological processes may be involved due to viral infection›s direct effects on the renin-angiotensin-aldosterone system, the activation of coagulopathy, the cytokine storm, and the activation of the immune system. Many glomerular diseases may be seen in these patients, like anca-associated vasculitis, membranous glomerulonephritis, and IgA nephropathy. Clinical case: We present a newly diagnosed crescentic IgA nephropathy (IgAN) case after a SARS-CoV-2 infection and vaccination. A 31-year-old man with no medical history presented with gross hematuria 24 hours after SARS-CoV-2 infection. Hematuria regressed spontaneously within three days. He was vaccinated with two doses of CoronaVac (Sinovac) three months after he had been infected by SARSCoV- 2. Then he was vaccinated with the Pfizer- BioNTech COVID-19 vaccine one month after the second dose of CoronaVac (Sinovac) vaccine. He presented with gross hematuria and subnephrotic proteinuria 24 hours after the first dose of the Pfizer-BioNTech COVID-19 vaccine. A kidney biopsy was performed and showed crescentic IgA nephropathy (IgAN). He was started on methylprednisolone and angiotensin receptor blocker. Patients who receive mRNA-based vaccines demonstrate robust antibody production against the receptor-binding domain (RBD) of the S1 protein. Similar to natural infection, due to the intense stimulation of immune response from mRNA-based vaccines compared to other vaccines, the patients may produce de novo antibodies, leading to IgA-containing immune-complex deposits. Conclusions: This case highlights the immunological effects of the novel mRNA-based SARS-CoV-2 vaccines. Nephrologists should be aware of new-onset hematuria or proteinuria after SARS-CoV-2 infection or mRNA-based SARSCoV- 2 vaccine.


REFERENCES

  1. Ghebreyesus TA, Organization WHOJWH. Directorgeneral’sremarks at the media briefing on 2019-nCoVon 11 February 2020. 2020;11.

  2. Faour WH, Choaib A, Issa E, Choueiry FE, ShbakloK, Alhajj M, et al. . Mechanisms of COVID-19-inducedkidney injury and current pharmacotherapies. 2021:1-18.

  3. Benedetti C, Waldman M, Zaza G, Riella LV, CravediPJFim. COVID-19 and the kidneys: an update. 2020;7.

  4. Koyama A, Sharmin S, Sakurai H, Shimizu Y,Hirayama K, Usui J, et al. . Staphylococcus aureus cellenvelope antigen is a new candidate for the induction ofIgA nephropathy. 2004;66(1):121-32.

  5. Suzuki S, Sato H, Tsukada H, Arakawa M, NakatomiYJTL. Haemophilus parainfluenzae antigen andantibody in renal biopsy samples and serum of patientswith IgA nephropathy. 1994;343(8888):12-6.

  6. Alonso M, Villanego F, Segurado Ó, Vigara LA,Orellana C, García T, et al. . De novo IgA nephropathyin a kidney transplant recipient after SARS-CoV-2vaccination. 2021.

  7. Watanabe TJPN. Henoch-Schönlein purpura followinginfluenza vaccinations during the pandemic of influenzaA (H1N1). 2011;26(5):795-8.

  8. García AR, Gallego E, Navarro JJNpodlSEN.Macroscopic hematuria after immunization withtetanus toxoid in a patient with IgA nephropathy.2002;22(2):210-1.

  9. Yeo SC, Goh SM, Barratt JJN. Is immunoglobulin Anephropathy different in different ethnic populations?2019;24(9):885-95.

  10. Placzek WJ, Yanagawa H, Makita Y, Renfrow MB,Julian BA, Rizk DV, et al. . Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients withIgA nephropathy. 2018;13(1): e0190967.

  11. Sundaram S, Soni M, Annigeri RJD, Research MSC,Reviews. Urine abnormalities predict acute kidneyinjury in COVID-19 patients: An analysis of 110 cases inChennai, South India. 2021;15(1):187-91.

  12. Kanbay M, Medetalibeyoglu A, Kanbay A, Cevik E,Tanriover C, Baygul A, et al. . Acute kidney injury inhospitalized COVID-19 patients. International urologyand nephrology. 2021:1-8.

  13. Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, etal. . Renal histopathological analysis of 26 postmortemfindings of patients with COVID-19 in China. Kidneyinternational. 2020;98(1):219-27.

  14. Ran E, Wang M, Wang Y, Liu R, Yi Y,Liu Y.New onset crescent Ig A nephropathy following the CoronaVacvaccine.2022. Medicine; 101:33.

  15. Kavukcu S, Soylu A, Sarioglu S et al. .Ig A nephropathyin mice following repeated adminisitration ofconjugated haemophilus influenza type B vaccine.Takai. J Exp Clin Med.1997; 22:167-74.

  16. Rahim SEG,Lin JT, Wang JC.A case of grosshematuria and ıgA nephropathy flare up followingSARS-Cov-2vaccination. Kidney Int.2021; 100:238.

  17. Waldman M, Sinaii N, Lerma EV, et al. . COVID-19Vaccination and New Onset Glomerular Disease:Results from the IRocGN2 International Registry.Kidney360. 2023;4(3):349-362.




2020     |     www.medigraphic.com